Related references
Note: Only part of the references are listed.Systems biology based drug repositioning for development of cancer therapy
Beste Turanli et al.
SEMINARS IN CANCER BIOLOGY (2021)
Biomedical data and computational models for drug repositioning: a comprehensive review
Huimin Luo et al.
BRIEFINGS IN BIOINFORMATICS (2021)
COGENT: evaluating the consistency of gene co-expression networks
Lyuba Bozhilova et al.
BIOINFORMATICS (2021)
Discovery of Functional Alternatively Spliced PKM Transcripts in Human Cancers
Xiangyu Li et al.
CANCERS (2021)
Ageing transcriptome meta-analysis reveals similarities and differences between key mammalian tissues
Daniel Palmer et al.
Aging-US (2021)
BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma
Yohei Sekino et al.
ONCOLOGY (2021)
Anaplastic lymphoma kinase inhibitor NVP-TAE684 suppresses the proliferation of human pancreatic adenocarcinoma cells
Hong-Quan Duong et al.
ONCOLOGY REPORTS (2021)
Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning
Xiangyu Li et al.
ISCIENCE (2021)
Computational drug repositioning based on multi-similarities bilinear matrix factorization
Mengyun Yang et al.
BRIEFINGS IN BIOINFORMATICS (2021)
LINCS Data Portal 2.0: next generation access point for perturbation-response signatures
Vasileios Stathias et al.
NUCLEIC ACIDS RESEARCH (2020)
Current Status of COVID-19 Therapies and Drug Repositioning Applications
Ozlem Altay et al.
ISCIENCE (2020)
Kidney Cancer, Version 1.2021 Featured Updates to the NCCN Guidelines
Robert J. Motzer et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Identification of Core Genes Involved in the Metastasis of Clear Cell Renal Cell Carcinoma
Rui Peng et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance
Magdalena Rausch et al.
CANCERS (2020)
Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma
Zhou Jiangqiao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Drug repositioning through integration of prior knowledge and projections of drugs and diseases
Ping Xuan et al.
BIOINFORMATICS (2019)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment
A. B. Nagaraj et al.
ONCOGENE (2018)
Systems biology in hepatology: approaches and applications
Adil Mardinoglu et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Personalised drug repositioning for Clear Cell Renal Cell Carcinoma using gene expression
Karel K. M. Koudijs et al.
SCIENTIFIC REPORTS (2018)
Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes
Gholamreza Bidkhori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Robin M. Meyers et al.
NATURE GENETICS (2017)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
Renal cell carcinoma
James J. Hsieh et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function
Shunan Ye et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Near-optimal probabilistic RNA-seq quantification
Nicolas L. Bray et al.
NATURE BIOTECHNOLOGY (2016)
A cloud-based workflow to quantify transcript-expression levels in public cancer compendia
P. J. Tatlow et al.
SCIENTIFIC REPORTS (2016)
Panobinostat for the Treatment of Multiple Myeloma
Jacob P. Laubach et al.
CLINICAL CANCER RESEARCH (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer
Luiz Fernando Zerbini et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells
Akinori Sato et al.
BMC UROLOGY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Integrated molecular analysis of clear-cell renal cell carcinoma
Yusuke Sato et al.
NATURE GENETICS (2013)
Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells
Hee Jung Urn et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells
C. Schonerr et al.
ONCOGENE (2012)
A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma
John D. Hainsworth et al.
CANCER INVESTIGATION (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer
Armelle Corpet et al.
EMBO JOURNAL (2011)
Inhibition of JAK2 Signaling by TG101209 Enhances Radiotherapy in Lung Cancer Models
Yunguang Sun et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+myeloma cells
Vijay Ramakrishnan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
BEDTools: a flexible suite of utilities for comparing genomic features
Aaron R. Quinlan et al.
BIOINFORMATICS (2010)
Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells
Joomin Lee et al.
CARCINOGENESIS (2010)
Regulation of Cyclin B2 Expression and Cell Cycle G2/M Transition by Menin
Ting Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Dual Degradation of Aurora A and B Kinases by the Histone Deacetylase Inhibitor LBH589 Induces G2-M Arrest and Apoptosis of Renal Cancer Cells
Tai-Lung Cha et al.
CLINICAL CANCER RESEARCH (2009)
Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis
Keqiang Zhang et al.
MOLECULAR CANCER (2009)
Understanding biological functions through molecular networks
Jing-Dong Jackie Han
CELL RESEARCH (2008)
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations
A. Pardanani et al.
LEUKEMIA (2007)
The crystal structure of human cyclin B
Edward T. Petri et al.
CELL CYCLE (2007)
Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK
Anna V. Galkin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
A human protein atlas for normal and cancer tissues based on antibody proteomics
M Uhlén et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Multidimensional drug profiling by automated microscopy
ZE Perlman et al.
SCIENCE (2004)
A gene-coexpression network for global discovery of conserved genetic modules
JM Stuart et al.
SCIENCE (2003)
Identification of genes periodically expressed in the human cell cycle and their expression in tumors
ML Whitfield et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Share Paper
